Shenzhen Zhijun Pharmaceutical Co.,Ltd. Profile:
Formerly named Shenzhen Pharmaceutical Factory, Shenzhen Zhijun Pharmaceutical. Co.ltd was established in 1985, playing a key role in SINOPHARM cephalosporin manufacturing lineup and also representing the core manufacturing enterprise in Shenzhen Accord Pharm.
With over 20 years’ endeavor, Zhijun has developed into a national High-Tech Enterprise focusing on Quality, Efficiency and Technology, with total assets equal to RMB900 million, annual turnover reach RMB1,200 million, and annual interest duty over RMB 100million. Now Zhijun has grown to a National Hi-Tech Enterprise among the list of Top 50 Pharmaceutical Factory in China.
Zhijun is strong in manufacturing Respiratory and Anti-infective pharmaceutical products, owns an international standardized R&D premise of 45,000 square kilometers, 9 production lines within 5 workshops which are powder for injection, oral solution and oral solid ( for cephalosporins and non-cephalosporins ). The company is in line with the EU GMP quality management, produced a series of market leading products with stringent quality control and management system and powerful marketing network. DaliXin (Cefuroxime axetil tablets and capsules) is the best player, leading the Dali brand and Zhijun brand to the top of the marketplace. The company is expanding the business in overseas markets and building strong reputation profile in global marketplace.
The Zhijun Product line has extended to the healthcare and OTC products. In the near future, Zhijun Pharma will take advantage of the SINOPHARM manufacture and sales integration, combine the API supplying to reduce the production cost and expand the scale, thus driving itself to be the core enterprise in the China Pharmaceutical Group Manufacturing lineup.
